Perspectives on experimental models of serotonin syndrome in zebrafish

Neurochemistry International

Volumn 62, Issue 6, 2013, Pages 893-902

  Stewart, Adam Michael ^a,b   Cachat, Jonathan ^a,c   Gaikwad, Siddharth ^a   Robinson, Kyle S L ^a,c   Gebhardt, Michael ^a,c   Kalueff, Allan V ^a,c  

^a ZENEREI Institute   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aquatic models; High throughput drug screening; HPLC analysis; Serotonin (5 HT); Serotonin syndrome (toxicity); Zebrafish

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; BUSPIRONE; CITALOPRAM; DESIPRAMINE; FLUOXETINE; LYSERGIDE; MESCALINE; METHYSERGIDE; QUIPAZINE; SELEGILINE; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG INTERACTION; EXPERIMENTAL MODEL; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; LOCOMOTION; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEROTONIN SYNDROME; ZEBRA FISH;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; HIGH-THROUGHPUT SCREENING ASSAYS; NEUROTOXICITY SYNDROMES; PHENOTYPE; SEROTONIN; SEROTONIN AGENTS; SEROTONIN SYNDROME; ZEBRAFISH;

ANIMALIA; DANIO RERIO; RODENTIA;

EID: 84875819602     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.02.018     Document Type: Article

References (168)

1. H.A. Abramson, and L.T. Evans Lysergic acid diethylamide (LSD 25). II. Psychobiological effects on the Siamese fighting fish Science 120 3128 1954 990 991
2. H.A. Abramson Effect of lysergic acid diethylamide on the surfacing behaviour of large carp Nature 193 1962 320 321
3. H.A. Abramson Lysergic Acid Diethylamide (Lsd-25). 34. Comparison with effect of psilocybin on the siamese fighting fish J. Psychol. 56 1963 363 374
4. Y. Agid How can drug discovery for psychiatric disorders be improved? Nat. Rev. Drug Discov. 6 3 2007 189 201
5. M.J. Airhart Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC) Neurotoxicol. Teratol. 29 6 2007 652 664
6. M. Aldeco Catalytic and inhibitor binding properties of zebrafish monoamine oxidase (zMAO): comparisons with human MAO A and MAO B Comp. Biochem. Physiol. B Biochem. Mol. Biol. 159 2 2011 78 83
7. D. Alsop, and M. Vijayan The zebrafish stress axis: Molecular fallout from the teleost-specific genome duplication event Gen. Comp. Endocrinol. 161 1 2008 62 66
8. D. Alsop, and M.M. Vijayan Development of the corticosteroid stress axis and receptor expression in zebrafish Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 3 2008 R711 R719
9. O. Anichtchik Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio) J. Comp. Neurol. 498 5 2006 593 610
10. J. Arbit Effects of LSD-25 upon Betta splendens: reliability of a bioassay technique J. Appl. Physiol. 10 2 1957 317 318
11. B.K. Arslan, and D.E. Edmondson Expression of zebrafish (Danio rerio) monoamine oxidase (MAO) in Pichia pastoris: purification and comparison with human MAO A and MAO B Protein Expr. Purif. 70 2 2010 290 297
12. J.R. Backstrom Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD) Neuropsychopharmacology 21 Suppl. 2 1999 77S 81S
13. M.G. Bankson, and K.A. Cunningham 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions J. Pharmacol. Exp. Ther. 297 3 2001 846 852
14. T.P. Barros Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery Br. J. Pharmacol. 154 7 2008 1400 1413
15. G. Bellipanni Cloning of two tryptophan hydroxylase genes expressed in the diencephalon of the developing zebrafish brain Mech. Dev. 119 Suppl. 1 2002 S215 S220
16. Z. Bencan Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety Pharmacol. Biochem. Behav. 94 1 2009 75 80
17. J.D. Best, and W.K. Alderton Zebrafish: an in vivo model for the study of neurological diseases Neuropsychiatr. Dis. Treat. 4 3 2008 567 576
18. A. Beulig, and J. Fowler Fish on Prozac: effect of serotonin reuptake inhibitors on cognition in goldfish Behav. Neurosci. 122 2 2008 426 432
19. J. Bilotta Ethanol exposure alters zebrafish development: a novel model of fetal alcohol syndrome Neurotoxicol. Teratol. 26 6 2004 737 743
20. P. Birmes Serotonin syndrome: a brief review CMAJ 168 11 2003 1439 1442
21. R.A. Bodner Serotonin syndrome Neurology 45 2 1995 219 223
22. D.F. Bogdanski Pharmacological studies with the serotonin precursor, 5-hydroxytryptophan J. Pharmacol. Exp. Ther. 122 2 1958 182 194
23. S. Boulet Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis J. Neurosci. 28 38 2008 9575 9584
24. Boyer, E. W., 2012 "Serotonin Syndrome." UpToDate. http://www.uptodate.com/contents/serotonin-syndrome, accessed 1/1/2013.
25. E.W. Boyer, and M. Shannon The serotonin syndrome N. Engl. J. Med. 352 11 2005 1112 1120
26. P. Brambilla Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data Pharmacopsychiatry 38 2 2005 69 77
27. S. Bretaud Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease Neurotoxicol. Teratol. 26 6 2004 857 864
28. B.B. Brodie Evidence that tranquilizing action of reserpine is associated with change in brain serotonin and not in brain norepinephrine J. Pharmacol. Exp. Ther. 129 1960 250 256
29. B.W. Brooks Aquatic ecotoxicology of fluoxetine Toxicol. Lett. 142 3 2003 169 183
30. E. Brustein Serotonin patterns locomotor network activity in the developing zebrafish by modulating quiescent periods J. Neurobiol. 57 3 2003 303 322
31. J.M. Cachat Modeling Stress and Anxiety in Zebrafish A.V. Kalueff, J. Cachat, Zebrafish Models in Neurobehavioral Research 2010 Humana Press New York
32. J. Cachat Three-dimensional neurophenotyping of adult zebrafish behavior PLoS One 6 3 2011 e17597
33. J. Cachat Unique and potent effects of acute ibogaine on zebrafish: The developing utility of novel aquatic models for hallucinogenic drug research Behav. Brain Res. 236C 2012 258 269
34. A. Capurro Aggressive behavior and jamming avoidance response in the weakly electric fish Gymnotus carapo: Effects of 3,4- methylenedioxymethamphetamine (MDMA) Comp. Biochem. Physiol. 118A 3 1997 831 840
35. M.D. Carrithers A Melanophore-based screening assay for erythropoietin receptors J. Biomol. Screen. 4 1 1999 9 14
36. D.L. Champagne Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research Behav. Brain Res. 214 2 2010 332 342
37. P.K. Chan Noninvasive technique for measurement of heartbeat regularity in zebrafish (Danio rerio) embryos BMC Biotechnol. 9 2009 11
38. D. Chatterjee, and R. Gerlai High precision liquid chromatography analysis of dopaminergic and serotoninergic responses to acute alcohol exposure in zebrafish Behav. Brain Res. 200 1 2009 208 213
39. R.D. Chessick Effect of Pretreatment with Tryptamine, Tryptophan and Dopa on Lsd Reaction in Tropical Fish Psychopharmacologia 5 1964 390 392
40. S. Clements, and C.B. Schreck Chronic administration of fluoxetine alters locomotor behavior, but does not potentiate the locomotor stimulating effects of CRH in juvenile Chinook salmon (Oncorhynchus tshawytscha) Comp. Biochem. Physiol. A Mol. Integr. Physiol. 147 1 2007 43 49
41. E.D. Clotfelter Serotonin decreases aggression via 5-HT1A receptors in the fighting fish Betta splendens Pharmacol. Biochem. Behav. 87 2 2007 222 231
42. C.J. Collins The zebrafish (Danio rerio) as a highly sensitive tool for screening hallucinogenic drug action: Lessons from mescaline and salvanorin A 2012 Tulane University Master of Science
43. M. Dickson, and J.P. Gagnon Key factors in the rising cost of new drug discovery and development Nat. Rev. Drug Discov. 3 5 2004 417 429
44. T. Dobzhansky Nothing in biology makes sense except in the light of evolution NABT 35 3 1973 125 129
45. T.P. Dooley Development of an in vitro primary screen for skin depigmentation and antimelanoma agents Skin Pharmacol. 7 4 1994 188 200
46. R.J. Egan Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish Behav. Brain Res. 205 1 2009 38 44
47. L. Flinn Zebrafish as a new animal model for movement disorders J. Neurochem. 106 5 2008 1991 1997
48. M.A. Fox Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice Int. J. Neuropsychopharmacol. 2009 1 11
49. M.A. Fox A pharmacological analysis of mice with a targeted disruption of the serotonin transporter Psychopharmacology (Berl) 195 2 2007 147 166
50. M.A. Fox Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice Neuropharmacology 53 5 2007 643 656
51. M. Fox Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice Psychopharmacology 201 2 2008 203 218
52. M.A. Fox Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT) Br. J. Pharmacol. 159 4 2010 879 887
53. Fox, M., et al., (2011). The serotonin syndrome in monoamine oxidase (MAO) AB knockout mice. Enhanced Behavioral Responses induced by 5-hydroxy-L-tryptophan (5-HTP) and Tramadol. Neuropsychopharmacology. American College of Neuropsychopharmacology (ACNP), 50th Annual Meeting, Waikoloa Beach, Hawaii.
54. J.P. Gabriel Serotonergic modulation of locomotion in zebrafish: endogenous release and synaptic mechanisms J. Neurosci. 29 33 2009 10387 10395
55. K.M. Gaworecki, and S.J. Klaine Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure Aquat. Toxicol. 88 4 2008 207 213
56. D.L. Gebauer Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol Pharmacol. Biochem. Behav. 99 2011 480 486
57. R. Gerlai Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects Pharmacol. Biochem. Behav. 67 4 2000 773 782
58. R. Gerlai Effects of acute and chronic ethanol exposure on the behavior of adult zebrafish (Danio rerio) Pharmacol. Biochem. Behav. 85 4 2006 752 761
59. H.H. Gettner Lysergic acid diethylamide (LSD 25) XXXX. Effect of pH on transport of methysergide and LSD 25 across gill membrane J. Psychol. 84(1st Half) 1973 111 118
60. H.H. Gettner Lysergic Acid Diethylamide (Lsd-25). Xxxv. comparison of effect on siamese fighting fish and goldfish J. Psychol. 58 1964 57 63
61. P.K. Gillman Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity Br. J. Anaesth. 95 4 2005 434 441
62. P.K. Gillman A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action Biol. Psychiatry 59 11 2006 1046 1051
63. L. Grossman Characterization of behavioral and endocrine effects of LSD on zebrafish Behav. Brain Res. 214 2 2010 277 284
64. D.J. Grunwald, and J.S. Eisen Headwaters of the zebrafish-emergence of a new model vertebrate Nat. Rev. Genet. 3 9 2002 717 724
65. S. Guo Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish? Genes Brain Behav. 3 2 2004 63 74
66. D.A. Gutman, and M.J. Owens Serotonin and norepinephrine transporter binding profile of SSRIs Essent. Psychopharmacol. 7 1 2006 35 41
67. A. Hausler Adrenalectomy, corticosteroid replacement and their importance for drug-induced memory-enhancement in mice J. Steroid Biochem. Mol. Biol. 41 3-8 1992 785 789
68. T. Henry, and M. Black Effect of Prozac on the survival and development of western mosquitofish 2004 Society of Environmental Toxicology and Chemistry Kennesaw, GA
69. T.B. Henry, and M.C. Black Acute and chronic toxicity of fluoxetine (selective serotonin reuptake inhibitor) in western mosquitofish Arch. Environ. Contam. Toxicol. 54 2 2008 325 330
70. K. Hirano Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors Br. J. Pharmacol. 144 5 2005 695 702
71. M.J. Hodgman Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy Hum. Exp. Toxicol. 16 1 1997 14 17
72. J.R. Homberg New perspectives on the neurodevelopmental effects of SSRIs Trends Pharmacol. Sci. 31 2 2010 60 65
73. T.R. Insel Possible development of the serotonin syndrome in man Am. J. Psychiatry 139 7 1982 954 955
74. G.K. Isbister Serotonin toxicity: a practical approach to diagnosis and treatment Med. J. Aust. 187 6 2007 361 365
75. C.K. Jayawickreme Functional screening of multiuse peptide libraries using melanophore bioassay Methods Mol. Biol. 87 1998 119 128
76. N.H. Jensen, and B.L. Roth Massively parallel screening of the receptorome Comb. Chem. High Throughput Screen. 11 6 2008 420 426
77. Z. Jie Trans-2-phenylcyclopropylamine induces nerve cells apoptosis in zebrafish mediated by depression of LSD1 activity Brain Res. Bull. 80 1-2 2009 79 84
78. A.V. Kalueff Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice Genes Brain Behav. 6 4 2007 389 400
79. A.V. Kalueff What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression Behav. Brain Res. 179 1 2007 1 18
80. A.V. Kalueff Perspectives on genetic animal models of serotonin toxicity Neurochem. Int. 52 4-5 2008 649 658
81. A.V. Kalueff Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes Neurosci. Biobehav. Rev. 34 3 2010 373 386
82. S.D. Karki, and G.R. Masood Combination risperidone and SSRI-induced serotonin syndrome Ann. Pharmacother. 37 3 2003 388 391
83. M.J. Kas Genetics of behavioural domains across the neuropsychiatric spectrum; of mice and men Mol. Psychiatry 12 4 2007 324 330
84. D. Kokel, and R.T. Peterson Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish Brief. Funct. Genomic. Proteomic. 7 6 2008 483 490
85. I. Koniari EComment: serotonin syndrome: pharmacogenomics and treatment Interact Cardiovasc. Thorac. Surg. 7 4 2008 657 658
86. D. Krasowska Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors J. Am. Acad. Dermatol. 56 5 2007 848 853
87. E.J. Kyzar Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology Prog. Neuropsychopharmacol. Biol. Psychiatry 37 1 2012 194 202
88. R. Lane, and D. Baldwin Selective serotonin reuptake inhibitor-induced serotonin syndrome: review J. Clin. Psychopharmacol. 17 3 1997 208 221
89. B. Lau Dissociation of food and opiate preference by a genetic mutation in zebrafish Genes Brain Behav. 5 7 2006 497 505
90. C. Lillesaar The serotonergic system in fish J. Chem. Neuroanat. 41 4 2011 294 308
91. B. Lockwood Acute effects of alcohol on larval zebrafish: a genetic system for large-scale screening Pharmacol. Biochem. Behav. 77 3 2004 647 654
92. M.A. Lopez Patino Gender differences in zebrafish responses to cocaine withdrawal Physiol. Behav. 95 1-2 2008 36 47
93. S.E. Lynn Fish on Prozac: a simple, noninvasive physiology laboratory investigating the mechanisms of aggressive behavior in Betta splendens Adv. Physiol. Educ. 31 4 2007 358 363
94. R. Mandrioli Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions Curr. Med. Chem. 19 12 2012 1846 1863
95. K.D. Mann Cardiac response to startle stimuli in larval zebrafish: sympathetic and parasympathetic components Am. J. Physiol. Regul. Integr. Comp. Physiol. 298 5 2010 R1288 R1297
96. T.G. Martin Serotonin syndrome Ann. Emerg. Med. 28 5 1996 520 526
97. P. Mathur, and S. Guo Differences of acute versus chronic ethanol exposure on anxiety-like behavioral responses in zebrafish Behav. Brain Res. 219 2 2011 234 239
98. Maximino, C. et al., in press. Role of serotonin in zebrafish (Danio rerio) anxiety: Relationship with serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine and para-chlorophenylalanine (pCPA) in two behavioral models. Neuropharmacology.
99. C. Maximino, and A.M. Herculano A review of monoaminergic neuropsychopharmacology in zebrafish Zebrafish 7 4 2010 359 378
100. C. Maximino Possible role of serotoninergic system in the neurobehavioral impairment induced by acute methylmercury exposure in zebrafish (Danio rerio) Neurotoxicol. Teratol. 33 6 2011 727 734
101. C. Maximino Pharmacological analysis of zebrafish (Danio rerio) scototaxis Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 624 631
102. C. Maximino The serotonergic system of zebrafish: genomics, neuroanatomy and neuropharmacology S. Hall, Serotonin: Biosynthesis, Regulation and Health Implications 2013 Nova Science New York
103. P. McGrath, and C.Q. Li Zebrafish: a predictive model for assessing drug-induced toxicity Drug Discov. Today 13 9-10 2008 394 401
104. A.G. Meehan Effects of serotonin on sympathetic noradrenergic transmission in rabbit isolated ear artery J. Cardiovasc. Pharmacol. 8 6 1986 1144 1153
105. D.J. Milan In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation Am. J. Physiol. Heart Circ. Physiol. 291 1 2006 H269 H273
106. L.J. Miller Serotoninergic activity stimulates melanin dispersion within dermal melanophores of newts Life Sci. 44 5 1989 355 359
107. K.C. Mills Serotonin syndrome. A clinical update Crit. Care Clin. 13 4 1997 763 783
108. E.M. Mills The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine J. Mol. Med. (Berl) 82 12 2004 787 799
109. M.B. Morando Fluoxetine treatment affects nitrogen waste excretion and osmoregulation in a marine teleost fish Aquat. Toxicol. 95 2 2009 164 171
110. M. Newman A zebrafish melanophore model of amyloid beta toxicity Zebrafish 7 2 2010 155 159
111. S. Nilsson, and R. Fange Adrenergic receptors in the swimbladder and gut of a teleost (Anguilla anguilla) Comp. Biochem. Physiol. 23 2 1967 661 664
112. K. Nisijima Risperidone counteracts lethality in an animal model of the serotonin syndrome Psychopharmacology (Berl) 150 1 2000 9 14
113. K. Nisijima Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome Brain Res. 890 1 2001 23 31
114. W.H. Norton Comparative analysis of serotonin receptor (HTR1A/HTR1B families) and transporter (slc6a4a/b) gene expression in the zebrafish brain J. Comp. Neurol. 511 4 2008 521 542
115. J.A. Oates, and A. Sjoerdsma Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor Neurology 10 1960 1076 1078
116. P. Panula Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases Zebrafish 3 2 2006 235 247
117. P. Panula The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases Neurobiol. Dis. 40 1 2010 46 57
118. A.C. Parrott Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity Pharmacol. Biochem. Behav. 71 4 2002 837 844
119. H.A. Perreault Fluoxetine treatment decreases territorial aggression in a coral reef fish Physiol. Behav. 79 4-5 2003 719 724
120. M.N. Potenza, and M.R. Lerner Characterization of a serotonin receptor endogenous to frog melanophores Naunyn Schmiedebergs Arch. Pharmacol. 349 1 1994 11 19
121. M.D. Rawlins Cutting the cost of drug development? Nat. Rev. Drug Discov. 3 4 2004 360 364
122. T.S. Ray Psychedelics and the human receptorome PLoS One 5 2 2010 e9019
123. J. Rihel Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation Science 327 5963 2010 348 351
124. A.L. Rubinstein Zebrafish assays for drug toxicity screening Expert Opin. Drug Metabol. Toxicol. 2 2 2006 231 240
125. J. Sackerman Zebrafish behavior in novel environments: effects of acute exposure to anxiolytic compounds and choice of danio rerio line Int. J. Comp. Psychol. 23 1 2010 43 61
126. V. Sallinen Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish J. Neurochem. 109 2 2009 403 415
127. M.L. Schneider Prenatal stress exposure alters postnatal behavioral expression under conditions of novelty challenge in rhesus monkey infants Dev. Psychobiol. 25 7 1992 529 540
128. H. Schneider Cloning and expression of a zebrafish 5-HT(2C) receptor gene Gene 502 2 2012 108 117
129. V. Setola Receptorome screening: a powerful, facile approach to better understand and engineer drugs Drug News Perspect. 22 8 2009 459 466
130. K. Shioda Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine Prog. Neuropsychopharmacol. Biol. Psychiatry 28 4 2004 633 640
131. K. Shioda Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome Neurosci. Lett. 482 3 2010 216 219
132. E.K. Silbergeld, and R.E. Hruska Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome" Psychopharmacology (Berl) 65 3 1979 233 237
133. L. Soorya Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders Child Adolesc. Psychiatr. Clin. N. Am. 17 4 2008 753 771 viii
134. L.J. Spanos, and B.K. Yamamoto Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat Pharmacol. Biochem. Behav. 32 4 1989 835 840
135. M. Spedding New directions for drug discovery Dialogues Clin. Neurosci. 8 3 2006 295 301
136. O. Spigset Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system Drug Saf. 20 3 1999 277 287
137. K.A. Sporer The serotonin syndrome. Implicated drugs, pathophysiology and management Drug Saf. 13 2 1995 94 104
138. H. Sternbach The serotonin syndrome Am. J. Psychiatry 148 6 1991 705 713
139. A. Stewart The Developing utility of zebrafish in modeling neurobehavioral disorders Int. J. Comp. Psychol. 23 1 2010 104 121
140. A. Stewart Zebrafish models to study drug abuse-related phenotypes Rev. Neurosci. 22 1 2010 95 105
141. A. Stewart Experimental models for anxiolytic drug discovery in the era of omes and omics Expert Opin. Drug Discov. 6 1-15 2011
142. A. Stewart Behavioral effects of MDMA ("Ecstasy") on adult zebrafish Behav. Pharmacol. 22 3 2011 275 280
143. A. Stewart Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models Prog. Neuropsychopharmacol. Biol. Psychiatry 35 6 2011 1421 1431
144. A. Stewart Modeling anxiety using adult zebrafish: a conceptual review Neuropharmacology 62 1 2012 135 143
145. C. Sun-Edelstein Drug-induced serotonin syndrome: a review Expert Opin. Drug Saf. 7 5 2008 587 596
146. S.T. Szabo, and P. Blier Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons Brain Res. 922 1 2001 9 20
147. S.T. Szabo, and P. Blier Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neurons J. Pharmacol. Exp. Ther. 302 3 2002 983 991
148. S.T. Szabo Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers Br. J. Pharmacol. 126 3 1999 568 571
149. M.T. Teh, and D. Sugden An endogenous 5-HT(7) receptor mediates pigment granule dispersion in Xenopus laevis melanophores Br. J. Pharmacol. 132 8 2001 1799 1808
150. H. Teraoka Hedgehog and Fgf signaling pathways regulate the development of tphR-expressing serotonergic raphe neurons in zebrafish embryos J. Neurobiol. 60 2004 275 288
151. K. van der Ven Effects of the antidepressant mianserin in zebrafish: molecular markers of endocrine disruption Chemosphere 65 10 2006 1836 1845
152. B. van der Zwaag Gene-network analysis identifies susceptibility genes related to glycobiology in autism PLoS One 4 5 2009 e5324
153. J.D. Vincent Evolution of monoamine receptors and the origin of motivational and emotional systems in vertebrates Bull Acad Natl Med 182 7 1998 1505 1514 discussion 1515-1506
154. V.M. Virador A standardized protocol for assessing regulators of pigmentation Anal. Biochem. 270 2 1999 207 219
155. E. Vuori Death following ingestion of MDMA (ecstasy) and moclobemide Addiction 98 3 2003 365 368
156. Y. Wang Characterization and expression of serotonin transporter genes in zebrafish Tohoku J. Exp. Med. 208 3 2006 267 274
157. Y. Wang Characterization and expression of serotonin transporter genes in zebrafish Tohoku J. Exp. Med. 208 2006 267 274
158. K.J. Webb Zebrafish reward mutants reveal novel transcripts mediating the behavioral effects of amphetamine Genome Biol. 10 7 2009 R81
159. S. Winberg Serotonin as a regulator of hypothalamic-pituitary-interrenal activity in teleost fish Neurosci. Lett. 230 2 1997 113 116
160. V.L. Winder Effects of fluoxetine exposure on serotonin-related activity in the sheepshead minnow (Cyprinodon variegatus) using LC/MS/MS detection and quantitation Comp. Biochem. Physiol. C Toxicol. Pharmacol. 149 4 2009 559 565
161. L.L. Wing 5HT-2 mediation of acute behavioral effects of hallucinogens in rats Psychopharmacology (Berl) 100 3 1990 417 425
162. K. Wong Analyzing habituation responses to novelty in zebrafish (Danio rerio) Behav. Brain Res. 208 2 2010 450 457
163. D.W. Woolley A Method for increasing brain serotonin without incurring some of the peripheral effects of the hormone Proc. Natl. Acad. Sci. USA 43 1 1957 128 133
164. A.L. Yonan Bioinformatic analysis of autism positional candidate genes using biological databases and computational gene network prediction Genes Brain Behav. 2 5 2003 303 320
165. L. Yu Cognitive aging in zebrafish PLoS One 1 2006 e14
166. I.V. Zhdanova Aging of the circadian system in zebrafish and the effects of melatonin on sleep and cognitive performance Brain Res. Bull. 75 2-4 2008 433 441
167. J. Zohar, and H.G. Westenberg Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors Acta Psychiatr. Scand. Suppl. 403 2000 39 49
168. L.I. Zon, and R.T. Peterson In vivo drug discovery in the zebrafish Nat. Rev. Drug Discov. 4 1 2005 35 44